+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Somatuline"

From
Somatostatin Analogs Market Report 2026 - Product Thumbnail Image

Somatostatin Analogs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • September 2024
  • 247 Pages
  • Global
From
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Somatuline is a brand of oncology drugs used to treat a variety of cancers, including neuroendocrine tumors, prostate cancer, and breast cancer. It is a long-acting somatostatin analogue, meaning it works by blocking the release of hormones that can cause cancer cells to grow. It is administered via subcutaneous injection, and is typically used in combination with other treatments such as chemotherapy and radiation therapy. Somatuline is manufactured by Ipsen, a French pharmaceutical company, and is available in the United States, Canada, and Europe. It is also available in other countries through Ipsen's international distribution network. Other companies that produce similar drugs include Novartis, Merck, and Pfizer. Show Less Read more